Clinical Features and Genetic Analysis of 48 Patients with Chronic Granulomatous Disease in a Single Center Study from Shanghai, China (2005–2015): New Studies and a Literature Review

Table 3

Immunologic investigations in CGD patients in the present study.

	Patients tested ()	Normal (/%)	Low (/%)	High (/%)
WBC (10^9 white blood cells/L)	48	6/13	0/0	42/88
Neutrophils (%)	48	2/4	2/4	44/92
Neutrophils (10^9 neutrophils/L)	48	4/8	0/0	44/92
Lymphocytes (%)	48	35/73	10/21	3/6
Lymphocytes (10^9 lymphocytes /L)	48	18/38	5/10	25/52
Eosinophils (%)	48	26/54	20/42	2/4
Eosinophils (10^9 eosinophils /L)	48	29/60	19/40	0/0
CD3 T lymphocytes (%)	46	45/98	0/0	1/2
CD4 T lymphocytes (%)	46	38/83	7/15	1/2
CD8 T lymphocytes (%)	46	44/97	1/2	1/2
B lymphocytes (%)	46	43/93	2/4	1/2
NK lymphocytes (%)	46	43/93	0/0	3/7
IgG levels (g/L)	48	0/0	6/13	42/88
IgA levels (g/L)	48	35/73	11/23	2/4
IgM levels (g/L)	48	44/92	1/2	3/6
IgE levels (g/L)	42	32/76	0/0	10/24